Contact
searchSearch
HMP Global
Login

Endometrial Cancer Excellence Forum Excellence Forum

Endometrial Cancer
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Anna Jo Smith, MD
Interview
Advancing Equity in Endometrial Cancer Trials: Strategies to Expand Access and Enrollment
10/06/2025
Anna Jo Smith, MD
Anna Jo Smith, MD, MPH, discusses strategies to advance equity in endometrial cancer clinical trial enrollment through clinician engagement, community partnerships, and inclusive trial design.
Anna Jo Smith, MD, MPH, discusses strategies to advance equity in endometrial cancer clinical trial enrollment through clinician engagement, community partnerships, and inclusive trial design.
Anna Jo Smith, MD, MPH,...
10/06/2025
Journal of Clinical Pathways
Headshots
Interview
Endometrial Cancer Risk Research Suggests Earlier Intervention Across Age Groups
09/17/2025
Mengmeng Du, ScD, MSc; Noah C. Peeri, PhD, MPH
In this interview, guest cancer epidemiologists share their findings on endometrial cancer risk in younger women, highlighting the powerful role of obesity and metabolic health, shared risk patterns across age groups, and the importance of...
In this interview, guest cancer epidemiologists share their findings on endometrial cancer risk in younger women, highlighting the powerful role of obesity and metabolic health, shared risk patterns across age groups, and the importance of...
In this interview, guest cancer...
09/17/2025
Journal of Clinical Pathways
Dana Chase, MD
Interview
The Impact of Dostarlimab and Patient-Centered Outcomes in the RUBY Trial for Endometrial Cancer
07/24/2025
Dana M. Chase, MD, FACOG
Explore how dostarlimab combined with carboplatin-paclitaxel improves quality-adjusted time without symptoms of disease progression or treatment toxicity in patients with advanced or recurrent endometrial cancer.
Explore how dostarlimab combined with carboplatin-paclitaxel improves quality-adjusted time without symptoms of disease progression or treatment toxicity in patients with advanced or recurrent endometrial cancer.
Explore how dostarlimab combined...
07/24/2025
Journal of Clinical Pathways
Sahana Somasegar
Interview
Rethinking Immunotherapy: A Case for Personalization in Advanced Endometrial Cancer
04/11/2025
Sahana Somasegar, MD, MS
A guest researcher shares a compelling case study that challenges conventional assumptions about immunotherapy in endometrial cancer, revealing how personalized treatment and multidisciplinary care enabled long-term disease control despite...
A guest researcher shares a compelling case study that challenges conventional assumptions about immunotherapy in endometrial cancer, revealing how personalized treatment and multidisciplinary care enabled long-term disease control despite...
A guest researcher shares a...
04/11/2025
Journal of Clinical Pathways
Brian S.
Interview
Key Advancements in Immunotherapy for Endometrial Cancer
03/13/2025
Brian M. Slomovitz, MD, MS
A guest expert discusses groundbreaking research on pembrolizumab in adjuvant treatment for endometrial cancer, highlighting the significant impact on reducing recurrence risk in patients with deficient mismatch repair and the need for...
A guest expert discusses groundbreaking research on pembrolizumab in adjuvant treatment for endometrial cancer, highlighting the significant impact on reducing recurrence risk in patients with deficient mismatch repair and the need for...
A guest expert discusses...
03/13/2025
Journal of Clinical Pathways
Gorzelitz
Interview
Incorporating Physical Activity Into Treatment Plans for Patients With Endometrial Cancer
02/12/2025
In an interview with a guest expert, learn how to improve care for patients with endometrial cancer through the lens of exercise and how to enhance motivation and accessibility.
In an interview with a guest expert, learn how to improve care for patients with endometrial cancer through the lens of exercise and how to enhance motivation and accessibility.
In an interview with a guest...
02/12/2025
Journal of Clinical Pathways
Romano Headshot
Interview
Personalizing Radiotherapy for Endometrial Cancer: Balancing Innovation and Quality of Life
01/17/2025
Kara D. Romano, MD
In this interview, Kara D. Romano, MD, University of Virginia, discusses advancements in radiation therapy for endometrial cancer, the integration of systemic therapies, the impact of treatment on quality of life, and the role of clinical...
In this interview, Kara D. Romano, MD, University of Virginia, discusses advancements in radiation therapy for endometrial cancer, the integration of systemic therapies, the impact of treatment on quality of life, and the role of clinical...
In this interview, Kara D....
01/17/2025
Journal of Clinical Pathways
Interview
Transforming Treatment Pathways for Endometrial Cancer
12/20/2024
Floortje Backes, MD
In this interview, Floortje Backes, MD, The Ohio State University College of Medicine, discusses advancements in novel treatments, the impact of molecular classifications, evolving surgical approaches, barriers to standardizing care, and...
In this interview, Floortje Backes, MD, The Ohio State University College of Medicine, discusses advancements in novel treatments, the impact of molecular classifications, evolving surgical approaches, barriers to standardizing care, and...
In this interview, Floortje...
12/20/2024
Journal of Clinical Pathways
Slomovitz Headshot
Interview
Molecular Classification Drives Advances in Endometrial Cancer Treatment
12/17/2024
Brian M. Slomovitz, MD, MS
In this interview, Brian M. Slomovitz, MD, MS, discusses the impact of molecular classification on endometrial cancer treatment, the role of biomarkers in guiding therapy, and the promise of emerging strategies to address challenges in...
In this interview, Brian M. Slomovitz, MD, MS, discusses the impact of molecular classification on endometrial cancer treatment, the role of biomarkers in guiding therapy, and the promise of emerging strategies to address challenges in...
In this interview, Brian M....
12/17/2024
Journal of Clinical Pathways
Dizon Headshot
Interview
Integrating Psychosocial Support and Quality of Life into Endometrial Cancer Pathways
12/12/2024
Don S. Dizon, MD
In this interview, Don S. Dizon, MD, discusses the need to address research gaps, integrate quality-of-life and psychosocial considerations, and improve care pathways to optimize outcomes for endometrial cancer patients.
In this interview, Don S. Dizon, MD, discusses the need to address research gaps, integrate quality-of-life and psychosocial considerations, and improve care pathways to optimize outcomes for endometrial cancer patients.
In this interview, Don S. Dizon,...
12/12/2024
Journal of Clinical Pathways
JCP Nov-Dec Cover

Current Issue

December 2025
Volume 11
Issue 6
Current Issue
Issue Archive

Special Reports

Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
08/15/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
08/15/2025
Journal of Clinical Pathways
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
08/15/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
08/15/2025
Journal of Clinical Pathways
Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
06/12/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
06/12/2025
Journal of Clinical Pathways
Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use